drug
copper histidinate
Marketedupdated 3mo agoby Sentynl Therapeutics Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying copper histidinate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 12, 2031
~4.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (1)
- Jan 12, 2031NCENew Chemical Entity (5y)4.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that